The biggest questions facing gene therapy, the XLMTM community, and Astellas after fourth patient death
After three patients died last year in an Astellas gene therapy trial, the company halted the study and began figuring out how to safely …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
